Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice

Author(s):
Wall, S.J. van der; Klok, F.A.; Exter, P.L. den; Barrios, D.; Morillo, R.; Cannegieter, S.C. (0000-0003-4707-2303); Jimenez, D.; Huisman, M.V. (0000-0003-1423-5348)
Published
2017
Publication type
Article / Letter to editor
cancerlow molecular weight heparinpatient adherencepatient compliancevenous thromboembolism
Date issued
2017-01-31
Language
English
Is part of
Journal of Thrombosis and Haemostasis (2017), Vol. 15, no. 1, p. 74-79
hdl
1887/114391
doi
10.1111/jth.13563